These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26093653)

  • 1. Endotoxin Elimination in Patients with Septic Shock: An Observation Study.
    Adamik B; Zielinski S; Smiechowicz J; Kübler A
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):475-83. PubMed ID: 26093653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new endotoxin adsorber in septic shock: observational case series.
    Ala-Kokko TI; Laurila J; Koskenkari J
    Blood Purif; 2011; 32(4):303-9. PubMed ID: 21893976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis.
    Reinhart K; Meier-Hellmann A; Beale R; Forst H; Boehm D; Willatts S; Rothe KF; Adolph M; Hoffmann JE; Boehme M; Bredle DL;
    Crit Care Med; 2004 Aug; 32(8):1662-8. PubMed ID: 15286541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study.
    Lee WY; Kim HJ; Kim EY
    Sci Rep; 2021 Dec; 11(1):24132. PubMed ID: 34916567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical significance of early high Endotoxin Activity in septic shock: An observational study.
    Bottiroli M; Monti G; Pinciroli R; Vecchi I; Terzi V; Ortisi G; Casella G; Fumagalli R
    J Crit Care; 2017 Oct; 41():124-129. PubMed ID: 28525777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin activity level and septic shock: a possible role for specific anti-endotoxin therapy?
    Monti G; Bottiroli M; Pizzilli G; Minnini M; Terzi V; Vecchi I; Gesu G; Brioschi P; Vesconi S; Casella G
    Contrib Nephrol; 2010; 167():102-110. PubMed ID: 20519904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin activity trend and multi-organ dysfunction in critically ill patients with septic shock, who received Polymyxin-B hemadsorption: A multicenter, prospective, observational study.
    Cutuli SL; De Rosa S; Ferrer R; Ruiz-Rodriguez JC; Forfori F; Ronco C; Antonelli M;
    Artif Organs; 2023 Aug; 47(8):1361-1370. PubMed ID: 37767775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column.
    Huang Z; Wang SR; Su W; Liu JY
    Ther Apher Dial; 2010 Dec; 14(6):596-602. PubMed ID: 21118369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection.
    Shum HP; Chan KC; Kwan MC; Yan WW
    Hong Kong Med J; 2013 Dec; 19(6):491-7. PubMed ID: 23650198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective adsorption of endotoxin in the complex treatment of patients with severe sepsis].
    Khubutiia MSh; Abakumov MM; Aleksandrova IV; Reĭ SI; Il'inskiĭ ME; Khvatov VB; Borovkova NV; Pertsev AS; Zinkin VIu
    Anesteziol Reanimatol; 2010; (5):65-9. PubMed ID: 21395145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of immobilized polymyxin B fiber in the treatment of septic shock associated with severe acute pancreatitis: report of two cases.
    Asanuma Y; Furuya T; Tanaka J; Sato T; Shibata S; Koyama K
    Surg Today; 1999; 29(11):1177-82. PubMed ID: 10552338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an extracorporeal endotoxin adsorber system during hyperdynamic porcine endotoxemia.
    Bracht H; Hauser B; Ivanyi Z; Asfar P; Ehrmann U; Brueckner UB; Georgieff M; Radermacher P; Buttenschon K
    Eur Surg Res; 2009; 43(1):53-60. PubMed ID: 19439972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
    Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
    Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of extracorporeal treatment with Lixelle on the mortality and inflammatory responses to endotoxin-induced shock in rats.
    Tsuda K; Taniguchi T
    Ther Apher Dial; 2006 Feb; 10(1):49-53. PubMed ID: 16556136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
    Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M
    J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.